Other Meeting

General Information

Co-Sponsors | Continuing Medical Education (CME) | Abstracts |

Co-Sponsors

• American Society of Nutrition
• Foundation for Osteoporosis Research and Education
• National Osteoporosis Foundation
• Orthopaedic Research Society
• The Endocrine Society
• The Paget Foundation for Paget's Disease of Bone and Related Disorders
• U.S. Bone and Joint Decade

Funding for this conference was made possible (in part) by 1 R13 DK 083816 -01 from NIDDK, NIA, NIAMS, NICHD and NINDS. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Continuing Medical Education

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Federation of American Societies for Experimental Biology (FASEB) and the American Society for Bone and Mineral Research (ASBMR). The Federation of American Societies for Experimental Biology is accredited by the ACCME to provide continuing medical education for physicians.

FASEB designates this educational activity for a maximum of 12.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME application forms are available online beginning April 27, 2009. Should you have questions, contact the FASEB Office of Scientific Meetings and Conferences, 9650 Rockville Pike, Bethesda, MD 20814, 301-643-7010; email: fasebcme@faseb.org

Please click here to view speaker and author disclosures.

Meeting Objectives
Upon completion of this activity, participants should be able to delineate specific stem cell determinants of osteoblastogenesis and the bone marrow interactions that underlie marrow adipogenesis during states of malnutrition, glucose intolerance and aging; understand the role of the central nervous system in the homeostatic regulation of bone turnover and in pathologic conditions; clarify how changes in body composition and metabolic syndrome affect bone remodeling and fracture risk; and define the importance of marrow adiposity in the pathogenesis of primary and secondary causes of osteoporosis.